0001622906-26-000003.txt : 20260925 0001622906-26-000003.hdr.sgml : 20260925 20260925085910 ACCESSION NUMBER: 0001622906-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260925 DATE AS OF CHANGE: 20260925 EFFECTIVENESS DATE: 20260925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dignify Therapeutics, LLC CENTRAL INDEX KEY: 0001622906 ORGANIZATION NAME: EIN: 464482373 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598830 FILM NUMBER: 261406391 BUSINESS ADDRESS: STREET 1: 2 DAVIS DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 9193718138 MAIL ADDRESS: STREET 1: PO BOX 13169 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001622906 Dignify Therapeutics, LLC 2 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 9194910369 DELAWARE None None Limited Liability Company true Anthony DiTonno 2 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Edward C. Burgard 2 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Eric Green 2 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Karl B. Thor 2 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Neil Kurtz 2 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Howard Palefsky 2 Davis Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b false 2026-09-15 false true true true false 0 3000000 800000 2200000 false 2 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Dignify Therapeutics, LLC Anthony DiTonno Anthony DiTonno Chief Executive Officer 2026-09-23